Treatment of raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5‐HT2) receptor
Year: 1984
Type: article
Study design: Clinical Trial
Source: Arthritis & Rheumatism
Authors: James R. Seibold, Anton H. M. Jageneau
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2012227782
